Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)

Market Cap	14.70B
Revenue (ttm)	559.22M
Net Income (ttm)	182.54M
Shares Out	137.75M
EPS (ttm)	1.33
PE Ratio	80.51
Forward PE	78.46
Dividend	0.80 (0.75%)
Ex-Dividend Date	May 29, 2025

Volume	336,777
Average Volume	539,692
Open	106.51
Previous Close	106.85
Day's Range	104.58 - 106.85
52-Week Range	95.28 - 132.00
Beta	0.11
RSI	46.58
Earnings Date	Oct 27, 2025

About SHA:688198

Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patches; bovine pericardial valves, as well as pulmonary artery valved pipeline, outflow tract single flap patches, etc. Its products are used in heart valv...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 611
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688198

Financial Performance

In 2024, SHA:688198's revenue was 501.88 million, an increase of 35.41% compared to the previous year's 370.64 million. Earnings were 146.33 million, an increase of 27.02%.